首页> 外文会议>Microfluidics, bioMEMS, and medical microsystems XV >Microfluidic devices for stem-cell cultivation, differentiation and toxicity testing
【24h】

Microfluidic devices for stem-cell cultivation, differentiation and toxicity testing

机译:用于干细胞培养,分化和毒性测试的微流控设备

获取原文
获取原文并翻译 | 示例

摘要

The development of new drugs is time-consuming, extremely expensive and often promising drug candidates fail in late stages of the development process due to the lack of suitable tools to either predict toxicological effects or to test drug candidates in physiologically relevant environments prior to clinical tests. We therefore try to develop diagnostic multi-organ microfluidic chips based on patient specific induced pluripotent stem cell (iPS) technology to explore liver dependent toxic effects of drugs on individual human tissues such as liver or kidney cells. Based initially on standardized microfluidic modules for cell culture, we have developed integrated microfluidic devices which contain different chambers for cell/tissue cultivation. The devices are manufactured using injection molding of thermoplastic polymers such as polystyrene or cyclo-olefin polymer. In the project, suitable surface modification methods of the used materials had to be explored. We have been able to successfully demonstrate the seeding, cultivation and further differentiation of modified iPS, as shown by the use of differentiation markers, thus providing a suitable platform for toxicity testing and potential tissue-tissue interactions.
机译:由于缺乏合适的工具来预测毒理作用或在临床测试之前在生理学相关的环境中测试候选药物,因此新药物的开发非常耗时,极其昂贵且通常很有希望的候选药物在开发过程的后期阶段失败。 。因此,我们尝试基于患者特异性诱导多能干细胞(iPS)技术开发诊断性多器官微流控芯片,以探索药物对单个人体组织(例如肝或肾细胞)的肝脏依赖性毒性作用。最初基于用于细胞培养的标准化微流体模块,我们开发了集成的微流体设备,其中包含用于细胞/组织培养的不同腔室。使用热塑性聚合物(例如聚苯乙烯或环烯烃聚合物)的注塑成型来制造设备。在该项目中,必须探索适用材料的表面改性方法。我们已经能够成功地证明修饰的iPS的播种,培养和进一步分化,如通过使用分化标记所显示的,从而为毒性测试和潜在的组织相互作用提供了合适的平台。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号